دورية أكاديمية
أعرض في EDS

KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.

التفاصيل البيبلوغرافية
العنوان: KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.
المؤلفون: Nemat-Gorgani N; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Edinur HA, Hollenbach JA, Traherne JA, Dunn PP, Chambers GK, Parham P, Norman PJ
المصدر: Immunogenetics [Immunogenetics] 2014 Nov; Vol. 66 (11), pp. 597-611. Date of Electronic Publication: 2014 Aug 21.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Springer Verlag Country of Publication: United States NLM ID: 0420404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1211 (Electronic) Linking ISSN: 00937711 NLM ISO Abbreviation: Immunogenetics Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Springer Verlag,
مواضيع طبية MeSH: HLA-B Antigens/*genetics , Native Hawaiian or Other Pacific Islander/*genetics , Population/*genetics , Receptors, KIR/*genetics, Alleles ; Haplotypes/genetics ; Humans ; New Zealand ; Polynesia
مستخلص: HLA class I molecules and killer cell immunoglobulin-like receptors (KIR) form a diverse system of ligands and receptors that individualize human immune systems in ways that improve the survival of individuals and populations. Human settlement of Oceania by island-hopping East and Southeast Asian migrants started ~3,500 years ago. Subsequently, New Zealand was reached ~750 years ago by ancestral Māori. To examine how this history impacted KIR and HLA diversity, and their functional interaction, we defined at high resolution the allelic and haplotype diversity of the 13 expressed KIR genes in 49 Māori and 34 Polynesians. Eighty KIR variants, including four 'new' alleles, were defined, as were 35 centromeric and 22 telomeric KIR region haplotypes, which combine to give >50 full-length KIR haplotypes. Two new and divergent variant KIR form part of a telomeric KIR haplotype, which appears derived from Papua New Guinea and was probably obtained by the Asian migrants en route to Polynesia. Māori and Polynesian KIR are very similar, but differ significantly from African, European, Japanese, and Amerindian KIR. Māori and Polynesians have high KIR haplotype diversity with corresponding allotype diversity being maintained throughout the KIR locus. Within the population, each individual has a unique combination of HLA class I and KIR. Characterizing Māori and Polynesians is a paucity of HLA-B allotypes recognized by KIR. Compensating for this deficiency are high frequencies (>50 %) of HLA-A allotypes recognized by KIR. These HLA-A allotypes are ones that modern humans likely acquired from archaic humans at a much earlier time.
References: J Immunol. 1997 May 1;158(9):4026-8. (PMID: 9126959)
Am J Hum Genet. 2003 May;72(5):1282-7. (PMID: 12644966)
Science. 2012 Oct 12;338(6104):222-6. (PMID: 22936568)
J Exp Med. 1995 Mar 1;181(3):1133-44. (PMID: 7532677)
N Engl J Med. 2012 Aug 30;367(9):805-16. (PMID: 22931314)
Hum Immunol. 2003 Jul;64(7):729-32. (PMID: 12826375)
Immunol Rev. 2006 Dec;214:186-201. (PMID: 17100885)
Blood. 2009 Dec 10;114(25):5182-90. (PMID: 19828694)
Am J Hum Genet. 2011 Feb 11;88(2):239-47. (PMID: 21295281)
Nature. 2011 Oct 23;479(7373):401-5. (PMID: 22020283)
J Immunol. 2002 Mar 1;168(5):2307-15. (PMID: 11859120)
Genome Res. 2012 Oct;22(10):1845-54. (PMID: 22948769)
Immunol Rev. 2013 Jul;254(1):245-64. (PMID: 23772624)
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18692-7. (PMID: 19837691)
Curr Opin Immunol. 2013 Feb;25(1):53-8. (PMID: 23270590)
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83. (PMID: 10781084)
Aust N Z J Obstet Gynaecol. 2012 Dec;52(6):552-8. (PMID: 23020751)
Nucleic Acids Res. 2013 Jan;41(Database issue):D1234-40. (PMID: 23180793)
Science. 2011 Oct 7;334(6052):89-94. (PMID: 21868630)
Mol Biol Evol. 2008 Aug;25(8):1750-61. (PMID: 18524786)
J Exp Med. 2006 Mar 20;203(3):633-45. (PMID: 16533882)
Immunogenetics. 2001;52(3-4):195-205. (PMID: 11220621)
Philos Trans R Soc Lond B Biol Sci. 2012 Mar 19;367(1590):812-9. (PMID: 22312048)
Philos Trans R Soc Lond B Biol Sci. 2012 Mar 19;367(1590):820-9. (PMID: 22312049)
J Immunol. 2007 Jan 1;178(1):33-7. (PMID: 17182537)
Immunogenetics. 2006 Jul;58(7):523-32. (PMID: 16733717)
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2662-7. (PMID: 24550293)
Tissue Antigens. 1984 Apr;23(4):217-28. (PMID: 6587614)
Annu Rev Genomics Hum Genet. 2006;7:277-300. (PMID: 16824023)
PLoS Genet. 2013 Oct;9(10):e1003938. (PMID: 24204327)
Annu Rev Immunol. 2005;23:225-74. (PMID: 15771571)
Hum Biol. 2005 Apr;77(2):157-77. (PMID: 16201134)
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20596-601. (PMID: 23184984)
Eur J Immunol. 2005 Jan;35(1):16-24. (PMID: 15580659)
Int J Immunogenet. 2013 Feb;40(1):39-45. (PMID: 23280119)
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1815-20. (PMID: 21187404)
Tissue Antigens. 2012 Dec;80(6):509-22. (PMID: 23137322)
J Exp Med. 2004 Oct 18;200(8):957-65. (PMID: 15477349)
PLoS One. 2012;7(11):e47491. (PMID: 23139747)
Mol Biol Evol. 2011 Oct;28(10):2731-9. (PMID: 21546353)
J Immunol. 2002 May 15;168(10):5047-57. (PMID: 11994457)
J Exp Med. 2009 Oct 26;206(11):2557-72. (PMID: 19858347)
Genes Immun. 2014 Jan;15(1):8-15. (PMID: 24173144)
PLoS One. 2012;7(11):e48769. (PMID: 23144962)
J Immunol. 2012 Aug 1;189(3):1418-30. (PMID: 22772445)
Front Immunol. 2014 Feb 26;5:72. (PMID: 24616720)
EMBO Rep. 2009 Oct;10(10):1103-10. (PMID: 19730434)
PLoS Genet. 2008 Jan;4(1):e19. (PMID: 18208337)
Immunity. 1997 Dec;7(6):753-63. (PMID: 9430221)
Arthritis Res Ther. 2013 Oct 22;15(5):R158. (PMID: 24286455)
Immunogenetics. 2011 Sep;63(9):549-59. (PMID: 21607693)
Nat Genet. 2007 Sep;39(9):1092-9. (PMID: 17694054)
Eur J Immunol. 2007 Jan;37(1):199-211. (PMID: 17171757)
Curr Biol. 2010 Nov 23;20(22):1983-92. (PMID: 21074440)
Front Immunol. 2014 Mar 07;5:87. (PMID: 24639677)
J Immunol. 2008 Mar 15;180(6):3969-79. (PMID: 18322206)
Nat Rev Immunol. 2005 Mar;5(3):201-14. (PMID: 15719024)
J Immunol. 1996 May 1;156(9):3098-101. (PMID: 8617928)
Am J Hum Genet. 2014 May 1;94(5):721-33. (PMID: 24726474)
Hum Immunol. 2009 Sep;70(9):733-7. (PMID: 19410616)
Tissue Antigens. 2006 Oct;68(4):297-302. (PMID: 17026464)
Nucleic Acids Res. 2011 Jan;39(Database issue):D913-9. (PMID: 21062830)
Nat Rev Immunol. 2013 Feb;13(2):133-44. (PMID: 23334245)
Hum Immunol. 2013 Sep;74(9):1119-29. (PMID: 23792058)
J Immunol. 2004 Jan 1;172(1):644-50. (PMID: 14688377)
J Clin Invest. 2008 Mar;118(3):1017-26. (PMID: 18246204)
J Immunol. 2013 Jun 15;190(12):6198-208. (PMID: 23686481)
Hum Mutat. 2001 Apr;17(4):271-80. (PMID: 11295824)
Immunogenetics. 2007 Feb;59(2):145-58. (PMID: 17200871)
Immunogenetics. 2012 Oct;64(10):719-37. (PMID: 22752190)
BMC Genomics. 2014 Apr 04;15:262. (PMID: 24708091)
J Immunol. 2014 Mar 15;192(6):2875-84. (PMID: 24563253)
Mol Biol Evol. 2006 Nov;23(11):2234-44. (PMID: 16923821)
J Immunol. 2003 Oct 1;171(7):3415-25. (PMID: 14500636)
Annu Rev Immunol. 2013;31:227-58. (PMID: 23516982)
معلومات مُعتمدة: R01 AI017892 United States AI NIAID NIH HHS; GM109030 United States GM NIGMS NIH HHS; United Kingdom MRC_ Medical Research Council; R01 GM109030 United States GM NIGMS NIH HHS; AI17892 United States AI NIAID NIH HHS
المشرفين على المادة: 0 (HLA-B Antigens)
0 (Receptors, KIR)
تواريخ الأحداث: Date Created: 20140821 Date Completed: 20141211 Latest Revision: 20211203
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4198482
DOI: 10.1007/s00251-014-0794-1
PMID: 25139336
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-1211
DOI:10.1007/s00251-014-0794-1